from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3615c/espC

LFCtreatmentdescriptionclass of inhibitor

0.125

Amikacinug/mL Amikacintranslation

-0.284

Cap5-10ug/mL Capreomycintranslation

-0.144

Rox10-50 ug/mL Roxithromycintranslation

0.489

SM2-5 ug/mL Streptomycintranslation

-0.208

Tet5-10 ug/mL Tetracyclinetranslation

-1.141

Rif0.2-5ug/mL Rifampicintranscription

-0.489

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.294

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.839

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.201

CPZ10-50 ug/mL Chlorpromazinerespiration

0.088

Clofazimine10-13 ug/mL Clofaziminerespiration

0.108

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.023

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.703

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.074

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.149

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.027

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.018

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.017

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.292

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.956

KCN5-20 ug/mL Potassium cyaniderespiration

1.820

NaN30.2-2 mM Sodium aziderespiration

0.568

Nigericin50 uM Nigericinrespiration

0.653

TRC10-150 ug/mL Triclosanrespiration

0.611

TRZ10-25 ug/mL Thioridazinerespiration

-0.848

Valinomycin0.5-10 uM Valinomycinrespiration

0.886

ZnSO42 mM ZnSO4respiration

-1.109

menadione6-10 ug/mL Menadionerespiration

0.074

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.038

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.114

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.251

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.733

NRP_1Non-replicating persistence stage 1dosRassociated

0.136

Amp0.2mg/mL AmpicillincellWall

-0.126

Cephalexin20-100 ug/mL CephalexincellWall

-1.061

Cerulenin0.32-5 ug/mL CerulenincellWall

0.009

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.837

EMB10-20 ug/mL EthambutolcellWall

-0.722

Eta12-40 ug/mL EthionamidecellWall

-0.881

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.625

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.769

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.358

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.158

BZA0.12 mg/mL BenzamidearomaticAmides

-0.401

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.523

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.353

H2O24 mM hydrogen peroxideDNAdamaging

0.411

Levo10 ug/mL LevofloxacinDNAdamaging

-0.205

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.336

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.289

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.968

UVUV-irradiationDNAdamaging

-0.076

ARP41-4 ug/mL Antitubercular compound ARP4?

0.308

Antimycin12.5-50 ug/mL Antimycin A?

0.148

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.302

PA_110-50 ug/mL Antitubercular compound PA-1?

0.024

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.946

PA8240.2-2 ug/mL PA-824?

-0.598

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.550

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.293

Verapamil50 uM Verapamil?

0.420

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.037

methoxatin10-20 ug/mL Methoxatin?